Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics IncfiledCriticalAcorda Therapeutics Inc
Publication of AR075414A1publicationCriticalpatent/AR075414A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Reivindicacion 1: Un método para tratar efectivamente la esclerosis multiple en un paciente en un período de tiempo cronico que comprende: administrar una cantidad terapéuticamente efectiva de 4-aminopiridina a dicho paciente durante un período de tiempo extendido. Reivindicacion 8: El método de cualquiera de las reivindicaciones anteriores, en donde dicha cantidad terapéuticamente efectiva de 4-aminopiridina es de 10 miligramos en una composicion de liberacion sostenida administrada dos veces al día.Claim 1: A method of effectively treating multiple sclerosis in a patient in a chronic period of time comprising: administering a therapeutically effective amount of 4-aminopyridine to said patient for an extended period of time. Claim 8: The method of any of the preceding claims, wherein said therapeutically effective amount of 4-aminopyridine is 10 milligrams in a sustained release composition administered twice daily.
ARP1001004032009-02-112010-02-12
COMPOSITIONS AND METHODS FOR EXTENDED THERAPY WITH AMINOPIRIDINS
AR075414A1
(en)
Topical anhydrous pharmaceutical composition, comprising niacin derivatives and an acceptable carrier, its application allows improved sexual well-being.
